Search research articles
Contact Us
Filters
Showing results (271-280 of 288) with videos related to
Page
of 29
Sort By:
Bone Marrow Transplantation
|
August 20, 2021
ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma
Pashna N Munshi, Mehdi Hamadani, Ambuj Kumar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 7, 2022
NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 11, 2018
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 6, 2020
Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 7, 2017
Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Cancer
|
April 13, 2018
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure
Sonali M Smith, James Godfrey, Kwang Woo Ahn, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 11, 2026
Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology
Ranjana H Advani, Christopher R Kelsey, Philippe Armand, et al.
Cancer
|
February 13, 2020
Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation
Deepa Jagadeesh, Navneet S Majhail, Yizeng He, et al.
Ebiomedicine
|
July 6, 2025
Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinations
Jérémie Decalf, Evangeline Toy, Dongping He, et al.
JAMA Oncology
|
May 6, 2021
Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant
Michael Scordo, Trent P Wang, Kwang W Ahn, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 288) with videos related to
Sort By:
Page
of 29
Bone Marrow Transplantation
|
August 20, 2021
ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma
Pashna N Munshi, Mehdi Hamadani, Ambuj Kumar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 7, 2022
NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 11, 2018
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 6, 2020
Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 7, 2017
Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Cancer
|
April 13, 2018
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure
Sonali M Smith, James Godfrey, Kwang Woo Ahn, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 11, 2026
Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology
Ranjana H Advani, Christopher R Kelsey, Philippe Armand, et al.
Cancer
|
February 13, 2020
Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation
Deepa Jagadeesh, Navneet S Majhail, Yizeng He, et al.
Ebiomedicine
|
July 6, 2025
Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinations
Jérémie Decalf, Evangeline Toy, Dongping He, et al.
JAMA Oncology
|
May 6, 2021
Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant
Michael Scordo, Trent P Wang, Kwang W Ahn, et al.
Page
of 29